Navigation Links
Novel Treatment Found To Prolong Survival Of Liver Cancer Patients

Surgery remains the most effective treatment option for patients with liver cancer. A cloud of confusion however remains regarding the best way to treat a patient who harbors a liver tumor that cannot be removed by surgery. //Infact very little surgical options are currently available for this group of patients.

Thanks to the perseverant work of the researchers who have now suggested a novel plan for combating these tumors using radiotherapy. The radiotherapy is targeted precisely at the tumor and is delivered in combination with chemotherapy approximated to a dose of 400 folds the conventional dose. The radiation oncologists designed a treatment that directly targets the tumor, using conformal radiation techniques that pinpoint precisely where the radiation beams go. This unique approach minimizes the radiation exposure to normal liver tissue.

The study was conducted on nearly 128 patients with either cancer of the bile duct, liver or colon that were regarded as inoperable. The study participants received radiation twice daily for two weeks, along with a continuous infusion of the chemotherapy drug floxuridine. The chemotherapy was administered through a catheter into the artery that supplies the liver. A two-week break was allowed before the same regime was continued for another two weeks.

Liver cancers have limited success with radiotherapy owing to the fact that the liver is extremely sensitive to radiation. In addition, multi-drug resistance is a common problem manifested in a majority of the liver cancers. Therefore has not been regarded as a viable option in the treatment strategy.

The study participants had a projected survival rate of eight or nine months. The treatment was found to prolong the survival rate to as much as 15.8 months in a statistically significant way in comparison to the traditional rates. Patients with liver, bile duct and colon cancer were found to live for an average of 15.2, 13.2 and 17.2 months respectively.

Nearly, one third of the treated patients had severe complications ranging from upper gastrointestinal ulcers or bleeding, liver disease to problems associated with the catheter. Research is also underway to further refine techniques for effective delivery of radiation. It has also been proposed to test liver function as a parallel approach to predict the response of the patients to the combined modality approach.


'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... , ... February 05, 2016 , ... ... setting the stage for new clinical and scientific initiatives have all marked the ... she was appointed President and CEO of the nation’s oldest cancer center, Candace ...
(Date:2/5/2016)... (PRWEB) , ... February 05, 2016 , ... ... College President George H. Van Allen have signed a joint enrollment and degree ... a seamless pathway toward associate and baccalaureate degrees at FHU|Dickson. , The ...
(Date:2/5/2016)... ... 05, 2016 , ... The American public tends to feel uncomfortable about drinking ... regular municipal or well water. The recent experience with lead contaminated water in Flint, ... long way toward increasing public acceptance of recycled waste water as drinking water. ...
(Date:2/5/2016)... ... 05, 2016 , ... At its annual meeting held last week, the American ... National Board of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We ... Chambers , APDA President and CEO. “Pat has tirelessly served APDA since 2001 when ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the defenses of the day ... feature of patients with eating disorders is significant self-criticism, and consequently these patients experience ... are regarded as maladaptive means for coping with this unease, but also leads to ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... CENTENNIAL, Colo. , Feb. 5, 2016  As ... about health. The multitude of recommended screenings and tests ... healthy aging a priority. However, for the majority of ... of proactive health planning. For the 37.5 million American ... time like the present to make hearing health a ...
(Date:2/5/2016)... 2016 Aethlon Medical, Inc. (Nasdaq: AEMD ), ... will be presenting at Source Capital Group,s 2016 Disruptive Growth ... at 2:15 p.m. ET on Wednesday, February 10, 2016.  ... taking place at 3:15 p.m. ET. http://www.aethlonmedical.com .  ... after the conclusion of the live event. The panel discussion ...
(Date:2/5/2016)... 2016  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... underwritten secondary offering of 11,027,558 shares of its common ... of Blackstone and Goldman Sachs.  The shares are being ... $96.45 per share. The selling stockholders will receive all ... nor any of its directors, officers or other stockholders ...
Breaking Medicine Technology: